Literature DB >> 15641693

PDX-1 expression in pancreatic ductal cells after partial pancreatectomy in adult rats.

Tao Liu1, Chunyou Wang, Chidan Wan, Jiongxin Xiong, Yiqin Xu, Feng Zhou.   

Abstract

To investigate the protein and mRNA expression of pancreas/duodenal homeobox-1 (PDX-1), a transcription factor as a marker for pancreatic stem cells, in pancreatic ductal cells of rats after partial (90%) pancreatectomy and evaluated the significance of the PDX-1 expression. Western blot and Reverse transcriptase-polymerase chain reaction (RT-PCR) were used to detect the expression of PDX-1 protein and mRNA respectively. PDX-1 protein was only faintly detected in pancreatic ductal cells on the day 1 after partial pancreatectomy. On the day 2 and 3 after operation in operation group, a 2-3 fold increased PDX-1 protein was observed, corresponding to the characteristic 42-kD protein in Western blot. There was significant difference between operation group and sham-operation group (P<0.05). PDX-1 protein expression on the day 5 and 7 after operation had already been no difference from control group (P>0.05). RT-PCR revealed the PDX-1 mRNA expression showed no significant difference between operation group at various time points and sham-operation group (P> 0.05). These results indicate that there was overexpression of PDX-1 in the cells of pancreatic epithelium during the regeneration of remnant pancreas after partial pancreatectomy in adult rats, suggesting the pancreatic stem cells in pancreatic ductal epithelial cells are involved in the regeneration of remnant pancreas and the expression of PDX-1 in ductal cells was regulated posttranscription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15641693     DOI: 10.1007/BF02831109

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes.

Authors:  H Zulewski; E J Abraham; M J Gerlach; P B Daniel; W Moritz; B Müller; M Vallejo; M K Thomas; J F Habener
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

2.  The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration.

Authors:  A Sharma; D H Zangen; P Reitz; M Taneja; M E Lissauer; C P Miller; G C Weir; J F Habener; S Bonner-Weir
Journal:  Diabetes       Date:  1999-03       Impact factor: 9.461

3.  Identification and characterization of small cells in the adult pancreas: potential progenitor cells?

Authors:  Maria Petropavlovskaia; Lawrence Rosenberg
Journal:  Cell Tissue Res       Date:  2002-08-10       Impact factor: 5.249

4.  Expression of pancreatic duodenal hoemobox-1 in pancreatic islet neogenesis after surgical wrapping in rats.

Authors:  Ryo Hosotani; Jun Ida; Masafumi Kogire; Koji Fujimoto; Ryuichiro Doi; Masayuki Imamura
Journal:  Surgery       Date:  2004-03       Impact factor: 3.982

5.  Stem cells in diabetes: what has been achieved.

Authors:  Susan Bonner-Weir
Journal:  Horm Res       Date:  2003

6.  Insulin-promoter-factor 1 is required for pancreas development in mice.

Authors:  J Jonsson; L Carlsson; T Edlund; H Edlund
Journal:  Nature       Date:  1994-10-13       Impact factor: 49.962

7.  PDX:PBX complexes are required for normal proliferation of pancreatic cells during development.

Authors:  S Dutta; M Gannon; B Peers; C Wright; S Bonner-Weir; M Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

8.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors.

Authors:  Guoqiang Gu; Jolanta Dubauskaite; Douglas A Melton
Journal:  Development       Date:  2002-05       Impact factor: 6.868

  8 in total
  4 in total

1.  Characterization of pancreatic stem cells derived from adult human pancreas ducts by fluorescence activated cell sorting.

Authors:  Han-Tso Lin; Shih-Hwa Chiou; Chung-Lan Kao; Yi-Ming Shyr; Chien-Jen Hsu; Yih-Wen Tarng; Larry L-T Ho; Ching-Fai Kwok; Hung-Hai Ku
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  PDX-1: demonstration of oncogenic properties in pancreatic cancer.

Authors:  Shi-He Liu; Sanjeet Patel; Marie-Claude Gingras; John Nemunaitis; Guisheng Zhou; Changyi Chen; Min Li; William Fisher; Richard Gibbs; F Charles Brunicardi
Journal:  Cancer       Date:  2010-09-30       Impact factor: 6.860

3.  Mesenchymal stem cells promote pancreatic β-cell regeneration through downregulation of FoxO1 pathway.

Authors:  Rahul Khatri; Sybille Mazurek; Sebastian Friedrich Petry; Thomas Linn
Journal:  Stem Cell Res Ther       Date:  2020-11-25       Impact factor: 6.832

4.  PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform.

Authors:  Shi-He Liu; Donald D Rao; John Nemunaitis; Neil Senzer; Guisheng Zhou; David Dawson; Marie-Claude Gingras; Zhaohui Wang; Richard Gibbs; Michael Norman; Nancy S Templeton; Francesco J Demayo; Bert O'Malley; Robbi Sanchez; William E Fisher; F Charles Brunicardi
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.